Aptose Biosciences (TSX:APS) Common Stock : C$609.78 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Common Stock?

Aptose Biosciences's quarterly common stock declined from Sep. 2023 (C$600.69 Mil) to Dec. 2023 (C$596.75 Mil) but then increased from Dec. 2023 (C$596.75 Mil) to Mar. 2024 (C$609.78 Mil).

Aptose Biosciences's annual common stock increased from Dec. 2021 (C$559.85 Mil) to Dec. 2022 (C$594.37 Mil) and increased from Dec. 2022 (C$594.37 Mil) to Dec. 2023 (C$596.75 Mil).

Aptose Biosciences Common Stock Historical Data

The historical data trend for Aptose Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Common Stock Chart

Aptose Biosciences Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

481.31

550.18

559.85

594.37

596.75

Aptose Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															599.24	583.39	600.69	596.75	609.78

Aptose Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Aptose Biosciences (TSX:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

APTO:USA LTI:Germany

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Executives

Bernd Robert Seizinger

Director

Aptose Biosciences (TSX:APS) Headlines

No Headlines